Impact Factor
Global reach, higher impact
Review Efferocytosis in heart failure: Mechanisms, dysregulation and therapeutic potential Full text PDF
Review Functionalized metallic nanomaterials, nanozymes and nanomotors for emerging tumor diagnosis and treatment: from design to theranostics strategies Full text PDF
Review Bacterial extracellular vesicles as multifaceted regulators of human diseases and emerging therapeutic platforms Full text PDF
Review The CXCR4-targeted theranostics era: a comprehensive review of a decade of progress (2015–2025) Full text PDF
Research Paper Mitochondria-targeting organoselenium theranostic radioprotectors for simultaneous treatment and imaging of radiation-induced liver injury Full text PDF
Research Paper A dual functional theranostic microneedle patch for immunomodulation and real time monitoring in diabetic wound therapy Full text PDF
Issue 10; 2026
Founding Editor-in-Chief:
Prof. Xiaoyuan (Shawn) Chen, PhD
Profile
Theranostics publishes innovative research articles reflecting the fields of in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensors, system biology and translational medicine, personalized medicine and a broad spectrum of biomedical research that can be applied to future theranostic applications.
- Theranostics is indexed by Science Citation Index (SCI) and MEDLINE. (Full index information)
- Full texts of articles in PubMed Central and Europe PMC. Abstracts in PubMed.
- (For NIH-funded researchers) Save time by submitting your paper to us - this journal is in full compliance with NIH Public Access Requirement.
The CXCR4-targeted theranostics era: a comprehensive review of a decade of progress (2015–2025)
Over the past decade, theranostics targeting the chemokine receptor CXCR4 have evolved from a promising concept into a clinical reality, revolutionizing the management of a diverse spectrum of diseases. This paradigm shift has been fueled by the development of [68Ga]Pentixafor, a high-affinity PET radiotracer that enables the precise, non-invasive visualization of CXCR4 expression in vivo. Its diagnostic prowess extends beyond conventional oncology, ...